Scientific And Regulatory Perspective On Monoclonal Antibody Biosimilars

Download Scientific And Regulatory Perspective On Monoclonal Antibody Biosimilars full books in PDF, epub, and Kindle. Read online free Scientific And Regulatory Perspective On Monoclonal Antibody Biosimilars ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!


Related Books

Scientific and Regulatory Perspective on Monoclonal Antibody Biosimilars
Language: en
Pages:
Authors: Po-Chih Wu
Categories: Medicine
Type: BOOK - Published: 2018 - Publisher:

DOWNLOAD EBOOK

Similar biotherapeutic products (SBPs), also called biosimilars, exhibit similar biological and clinical properties to authorized reference products. Biosimilar
Biosimilars of Monoclonal Antibodies
Language: en
Pages: 645
Authors: Cheng Liu
Categories: Medical
Type: BOOK - Published: 2016-12-12 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all asp
Biopharmaceuticals
Language: en
Pages: 140
Authors: Ming-Kung Yeh
Categories: Medical
Type: BOOK - Published: 2018-09-19 - Publisher: BoD – Books on Demand

DOWNLOAD EBOOK

Biopharmaceuticals are derived from biological sources, either live organisms or their active components; nowadays, they are mainly produced by biotechnologies.
Biosimilars
Language: en
Pages: 713
Authors: Hiten J. Gutka
Categories: Medical
Type: BOOK - Published: 2018-12-13 - Publisher: Springer

DOWNLOAD EBOOK

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars.
Current Trends in Monoclonal Antibody Development and Manufacturing
Language: en
Pages: 354
Authors: Steven J. Shire
Categories: Medical
Type: BOOK - Published: 2012-02-25 - Publisher: Springer

DOWNLOAD EBOOK

Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have b